Article
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs
Rating:
0.0
Views:
46
Likes:
1
Library:
1
Novo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by their availability.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value